BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

TAE Life Sciences' Neutron Beam System Approved, Paving Way for BNCT Trials in China

TAE Life Sciences, a pioneer in advancing Boron Neutron Capture Therapy (BNCT) for cancer treatment, proudly announces the successful completion of a...

April 04, 2024 | News

RemeGen's Telitacicept Secures FDA Fast Track Status for Primary Sjögren's Syndrome Treatment

RemeGen , a commercial-stage biotechnology company, obtained Fast Track Designation (FTD) by the United States Food and Drug Administration (FDA) rec...

April 03, 2024 | News

Innovent and HUTCHMED's Endometrial Cancer Therapy Receives Priority Review by China's NMPA

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

April 03, 2024 | News

GenFleet Therapeutics Collaborates with BeiGene for Advanced Lymphoma Trial

GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced it has entered into ...

March 29, 2024 | News

Recbio and Rongsheng Biotech Sign Partnership for New Adjuvant Vaccine Project

Jiangsu Recbio Technology Co., Ltd. (hereafter referred to as Recbio; stock code: 02179.HK) and Shanghai Rongsheng Biotech Co.,Ltd.(hereafter referred...

March 27, 2024 | Company results

Scivita Medical Expands Collaboration with Boston Scientific

The introduction of iterative endoscopic technology has brought about a positive transformation in the field of endoscopy, making it an interventional tool...

March 26, 2024 | News

AriBio Secures Exclusive $770M Deal for Alzheimer's Drug in China

AriBio Co., Ltd. (AriBio), announces signing of exclusive marketing rights for AR1001, an investigational drug for early Alzheimer’s disease, in Chin...

March 25, 2024 | News

Sino Biological Announces Services Partnership with Rapid Novor

This collaboration marks a significant stride in biotechnological services, covering major geographical regions including China, Singapore, Thailan...

March 22, 2024 | News

Antengene Advances ATG-022 in Phase II CLINCH Study for Solid Tumors in China and Australia,

Antengene Corporation Limited, a prominent global biopharmaceutical entity focused on the development and commercialization of pion...

March 21, 2024 | News

Chipscreen Biosciences Announces Successful Phase II Trial of Chiglitazar for NASH Treatment

The CGZ203 study, a randomized, double-blind, placebo-controlled trial conducted across 24 national clinical sites, aimed to assess the saf...

March 19, 2024 | News

KeChow Pharma's Tunlametinib Receives Historic Approval in China for Advanced Melanoma Treatment

KeChow Pharma, a commercial-stage pharmaceutical company focused on developing and commercializing differentiated small molecule therapeutics for cancer, t...

March 19, 2024 | News

CStone's Sugemalimab Granted Historic Approval in China for Gastric Cancer Treatment

CStone Pharmaceuticals has achieved a significant milestone with the approval of sugemalimab (Cejemly®) by the National Medical Products Administration...

March 18, 2024 | News

Sanyou Biopharmaceuticals Launches Groundbreaking Intelligent Innovative Biologics R&D Service Platform

Sanyou Biopharmaceutical Co., Ltd. is delighted to announce the official launch of the "Sanyou Intelligent Innovative Biologics R&D Service Platform," ...

March 13, 2024 | News

FDA Grants Nefecon® Orphan Drug Exclusivity for Seven Years

Everest Medicines licensing partner Calliditas Therapeutics AB announced that the U.S. FDA has granted an orphan drug exclusivity period of seven yea...

March 12, 2024 | News

Stay Connected